Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19

Affiliations

• ¹ Fourth Department of Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing 100069, China.
• ² Department of Respiratory and Critical Care Medicine, Beijing Engineering Research Center of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100043, China.
• ³ First Department of Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing 100069, China.
• ⁴ Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing 100069, China.
• ⁵ Second Department of Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing 100069, China.
• ⁶ School of Management, University of Science and Technology of China, Hefei 230026, China.
• ⁷ Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, China.
• ⁸ Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing 100069, China. Electronic address: yfcyt@139.com.
• ⁹ Department of Respiratory and Critical Care Medicine, Beijing You'An Hospital, Capital Medical University, Beijing 100069, China. Electronic address: mayingminicu@126.com.